Several recent CVOTs have shown that GLP-1RAs can reduce the decline of estimated GFR (eGFR) and delay the onset of the occurrence of proteinuria in patients with T2DM [4, 22, 26, 46, 47]
In addition, severe MAA had a higher odds ratio than other important risk factors consisting of increased Body Mass Index, hypertension, dyslipidemia, and diabetes
Many patients ask why weight loss drugs including GLP-1 pills cost so much (in some instances, close to $1,000 a month)
& Liebl, A
Ozempic has also been shown to greatly reduce the risk of major cardiovascular events
High body mass index (BMI) has also emerged as a major risk factor for reduced life expectancy in the United States, ranking among the top five risk factors that lead to a decline in life expectancy for the past 10 years (214)Ng, Marie et al